Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics
Expert Review of Clinical Pharmacology · 2024
DOI: 10.1080/17512433.2024.2317954 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2024. Verfasst von Nicole F Maranchick und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Pharmacokinetics Lab, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gaines…. Hauptthemen laut MEDLINE: Drug Interactions, Tuberculosis, HIV Infections, Antitubercular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 141 Literaturangaben. Gefördert von: No funding.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease Pharmacokinetics Lab, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA.
- Emerging Pathogens Institute, University of Florida, Gainesville, USA.
- Division of Infectious Diseases and Global Medicine, College of Medicine, University of Florida, Gainesville, USA.
Förderung
- No funding
Zitieren
APA
Maranchick, N. F., Kwara, A., & Peloquin, C. A. (2024). Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2024.2317954
Vancouver
Maranchick NF, Kwara A, Peloquin CA. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics. Expert Review of Clinical Pharmacology. 2024. doi:10.1080/17512433.2024.2317954
BibTeX
@article{Maranchick2024,
author = {Maranchick, Nicole F and Kwara, Awewura and Peloquin, Charles A},
title = {Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics},
journal = {Expert Review of Clinical Pharmacology},
year = {2024},
doi = {10.1080/17512433.2024.2317954}
}
EUVIMED